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Self-tests are performed and interpreted autonomously by a person without involving a 
healthcare professional or certified laboratory. To gain insight into the usage of purchased 
HIV self-tests (HIVST) among migrants living in high-income countries, we studied the 
prevalence and determinants of HIVST usage among migrants living in the United Kingdom 
(UK), France, and the Netherlands. 
Methods 
We used web-based questionnaire data collected between April 2014 and July 2015 among 
migrants living in the UK, France, and the Netherlands who participated in the cross-
sectional community survey of the aMASE (advancing Migrant Access to Health Services in 
Europe) study. HIVST usage in the preceding 12 months and corresponding 95%-
confidence intervals (CI) were calculated. Using univariate logistic regression analyses, 
determinants of HIVST usage were evaluated.  
Results  
Among 477 migrants living in the UK (n=235), France (n=98) and the Netherlands (n=144) 
HIVST usage in the preceding 12 months was 1.89% (9/477, 95%-CI:0.66-3.11%). As all 9 
HIVST users were men who have sex with men (MSM), we restricted our univariate analyses 
to MSM (n=240). HIVST usage was borderline significantly lower among MSM living in the 
France and the Netherlands compared to those living in the UK (UK: ref; France: OR:0.20, 
95%-CI:0.03-1.14; the Netherlands: OR:0.06, 95%-CI:0.00-1.05). Age, region of birth, 
educational level, registration at a general practitioner, recent number of male sexual 
partners and hard drug use were not associated with HIVST usage among MSM. 
Conclusions 
HIVST usage among migrants from the UK, France, and the Netherlands was relatively low 
between 2014 and 2015 but higher among migrant MSM. To increase HIV testing rates 
among migrants, programs need to be developed to promote HIVST among this group. 
Also, as more countries approve usage of HIVST, systems need to be established to ensure 
linkage to confirmatory testing and care following a positive test. 
 





Self-tests are tests that can be performed and interpreted autonomously by lay 
persons without involving healthcare professionals or certified laboratories.[1] The World 
Health Organization (WHO) currently recommends the usage of self-tests for HIV 
infections (HIVST) as an additional approach to HIV testing services, as it could increase HIV 
testing rates. [1,2] However, ensuring linkage to confirmatory testing and specialist care for 
those with a positive HIVST result remains a concern.  
Within Europe, migrants represent a significant group in the HIV epidemic, and 
migrants are more likely to be undiagnosed or diagnosed late compared with non-
migrants.[3] HIVST may help overcome barriers migrants encounter in accessing traditional 
testing services and therefore increase HIV testing rates among this group.[1,4]   
To gain more insight into recent usage of purchased HIVST by migrants living in 
Europe, we studied its prevalence and determinants among migrants living in the UK, 
France, and in the Netherlands. Furthermore, we studied the HIVST positivity rate and the 
extent to which users attend professional healthcare providers for confirmation testing to 




We included participants of the web-based community survey of the aMASE (advancing 
Migrant Access to health Services in Europe) study. Detailed information on the aMASE 
study is provided elsewhere.[5,6] Briefly, the cross-sectional aMASE community survey 
aimed to identify the structural, cultural, and financial barriers to HIV prevention, diagnosis, 
and treatment in migrant populations. The community survey was promoted between April 
2014 and July 2015 via social marketing and community participatory methods in nine 
countries (Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal, Spain, and 
the United Kingdom), although migrants aged 18 or older living in all countries of the World 
Health Organization (WHO) European area were eligible. Migrants were defined as foreign-
born individuals intending to live in their current country of residence for ≥6 months. 
Participants completed a questionnaire (available in 14 languages) which included (1) 
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detailed socio-demographic data and extensive migration history data, (2) sexual and HIV 
risk behaviour, (3) use of health services, and (4) experiences of living with HIV, including 
stigma and discrimination. HIVST questions were only included in the survey of people who 
reported living in the UK, France, and the Netherlands. Hence, our study only includes 
aMASE participants living in the UK, France, and the Netherlands. Questions addressed 
HIVST usage in the preceding 12 months, the HIVST result, whether persons went to a 
professional healthcare provider for confirmatory testing, and the confirmation test results. 
HIV-positive participants diagnosed more than one year prior to survey completion were 
excluded, as were participants who did not answer the question regarding HIVST use.   
Participant characteristics (age, sexual orientation, educational level, country of 
residence, years since migration, and region of birth) and the percentage and 
corresponding 95%-confidence intervals (CI) of HIVST usage were calculated. Among 
HIVST users, HIVST results and follow-up testing behaviour were described. To evaluate 
determinants of HIVST usage we calculated odds ratios (ORs) and 95%-CI by by a univariate 
logistic regression model adapted for rare events and fit using penalized-maximum 
likelihood estimation. Potential determinants including country of residence, age (<27 
years/27-35 years/>35 years), region of birth (developing/developed region based on UN-
classification), educational level (lower secondary level/upper secondary level or more), 
registration at a general practitioner (no/yes), number of sexual partners in the preceding 
12 months (0-5/6-20/>21), and hard drug use in the preceding 5 years (no/yes). A p-value 
<0.05 was considered statistically significant. Analyses were performed using STATA 
Intercooled 13.1 (STATA Corporation, College Station, Texas, USA). 
Ethical approval was obtained from the London-Bentham Research Ethics 
Committee (11/LO/1600) and the ethics committee of the Academic Medical Center of 




In total, 552 migrants participated in the aMASE community survey in the UK 
(n=265), France (n=126), and the Netherlands (n=161). Of those, 70 HIV-positive 
participants were diagnosed more than one year before survey completion and five 
participants with missing HIVST usage data were excluded from the analyses. Of the 477 
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included participants, median age was 34 (IQR 27-43) years, 91% (n=435) had finished at 
least their upper secondary educational level, and 36% (n=171) were women, 13% (n=64) 
were heterosexual men, 50% (n=240) were men having sex with men (MSM), and 0.42% 
(n=2) transgender people. Median years since migration was 7 (IQR 3-13), and 50% (n=236) 
were born in another European country, 21% (n=102) in Latin America/Caribbean, 14% 
(n=67) in Africa, 7% (n=33) in Asia and 8% (n=39) in the rest of the world. 
 HIVST-usage in the preceding 12 months was 1.89% (9/477, 95%-CI: 0.66-3.11%). 
Eight HIVST users reported their HIVST result was negative and one reported a 
failed/indeterminate result. Of those with a negative HIVST result, four (50%) went to a 
professional healthcare provider for confirmation testing, and all confirmation HIV tests 
were negative. The participant whose test failed or was indeterminate did not seek 
confirmation testing.  
 All nine HIVST users were MSM, corresponding to a HIVST-usage of 3.75% (9/240, 
95% CI:1.33-6.17%) among MSM. Of all HIVST users, five went to a sexual health clinic or 
HIV testing clinic for their last HIV test, while one went to a private clinic, and three used a 
self-test for their last HIV test. As these HIVST users were all MSM, we included only MSM 
in our univariate analyses (Table 1). HIVST usage was borderline significantly lower among 
MSM living in the France and the Netherlands compared to those living in the UK (UK: ref; 
France: OR:0.20, 95%-CI:0.03-1.14; the Netherlands: OR:0.06, 95%-CI:0.00-1.05). No other 




This study shows that the overall HIVST usage in the preceding 12 months among migrants 
living in the UK, France, and the Netherlands is low (2%), but higher among MSM (4%). 
Among MSM, HIVST usage was higher in those living in the UK compared to those living in 
France and the Netherlands. 
The low overall HIVST usage is in line with findings of previous European studies 
conducted among French MSM (2009),[7] Spanish attendees of a street-based HIV-testing 
programme (2010-2012)[8] and a Dutch study among the general population and sexual 
risk groups (2007-2015).[9] However, a Chinese study showed that 20% of Chinese MSM 
reported prior HIVST usage.[10] The differences between the HIVST usage prevalence 
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between Europe and China might be explained by Europe’s legal restrictions on selling 
HIVST, whereas China has a national policy supporting HIVST. In Europe, only the UK and 
France have recently approved HIVST for sale (UK: April 2015; France: September 
2015).[11] Although UK approval of HIVST took place during recruitment for this study, five 
out of eight UK self-test users participated in this study prior to the HIVST approval. Hence 
the approval may only partially explain the lower number of HIVST users in France and the 
Netherlands compared to the UK. Data from the UK showed that in the first nine months 
after HIVST approval approximately 25,000 tests were sold, indicating that usage is likely to 
increase as more countries approve HIVST usage as the tests become more easily 
available.[12] It is therefore important to remove legislative barriers to and promote HIVST 
access and establish systems to provide linkage of users to confirmatory testing and care 
following a positive test. 
In our study, HIVST usage was reported only by migrant MSM, not by heterosexual 
migrants. To successfully implement HIVST as an additional approach to increase HIV 
testing rates among migrants, HIVST awareness and potential motives and barriers to 
usage should be further explored especially among heterosexual migrants.  
 Our results further show that most HIVST users had a negative self-test result, and 
50% went for confirmation testing. When questioned about the location of their last HIV 
test, the majority of self-test users reported a professional sexual health clinic or HIV 
testing clinic. These results suggest that some HIVST users might not experience barriers in 
accessing regular HIV healthcare services but rather use HIVST alongside regular services. A 
previous qualitative study among UK MSM also described self-testing as an opportunity to 
‘top-up’ between other tests.[13]   
  Regarding study strengths, we were able to assess HIVST usage among a diverse 
sample of heterosexual and MSM migrants living in three European countries. Limitations 
include the representativeness of our study population. Since we used convenience 
sampling and a web-based questionnaire which generally attracts persons with higher 
(digital) literacy, our population is unlikely to represent the whole migrant population in the 
UK, France and the Netherlands. Also, due to the small number of HIVST users we had low 
statistical power to assess determinants of HIVST usage.  
 In conclusion, HIVST usage among migrants from the UK, France, and the 
Netherlands participating in an HIV community survey was relatively low between 2014 and 
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2015, but higher among migrant MSM. As HIVST have the potential to increase testing 
rates and decrease late diagnoses, programmes should be developed to promote and 
facilitate HIVST among migrants, especially among heterosexual migrants. To evaluate 
such programs, HIVST usage should be closely monitored. In addition, as more countries 
approve HIVST, systems should be established to ensure linkage to confirmatory testing 
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Table 1: Potential determinants of HIV self-test usage among 240 migrant men who have sex with men 






(%) OR 95%-CI p-value 
Current country of residence 
United Kingdom 8/88 9.09% 1 
 
0.042 
France 1/73 1.37% 0.20 0.03-1.14  
The Netherlands 0/79 0.00% 0.06 0.00-1.05  
     
 
Age 
<27 year 1/70 1.43% 1 
 
0.394 
27-35 year 3/89 3.37% 1.87 0.27-13.03  
>35 year 5/81 6.17% 3.33 0.53-20.86  
     
 
Region of birth 
Developing regions 1/108 0.93% 1 
 
0.076 
Developed regions 8/132 6.06% 4.89 0.85-28.29  
     
 
Educational level 
Upper secondary or more 9/221 4.07% 1 
 
0.705 
Lower secondary or less  0/19 0.00% 0.57 0.03-10.23  
 
 
Registered at a general practitioner 
No 1/59 1.69% 1 
 
0.471 
Yes 8/181 4.42% 1.91 0.33-11.12  
     
 
Number of male sexual partners in the preceding 12 months 
0-5 2/72 2.78% 1 
 
0.939 
6-20 4/99 4.04% 1.33 0.27-6.43  
>21 2/61 3.28% 1.18 0.19-7.07  
Missing 1/8 0.13% 
  
 
     
 
Hard drug use in the preceding 5 years 
No 3/129 2.33% 1 
 
0.231 
Yes 6/110 5.45% 2.25 0.60-8.46  
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